{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:34:02Z","timestamp":1780457642797,"version":"3.54.1"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Centre des Ressources Biologiques (CRB)"},{"name":"Hospitalo-Universitaire de Montpellier, France"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Distinction between primary cutaneous follicular lymphoma (<jats:styled-content style=\"fixed-case\">PCFL<\/jats:styled-content>) and primary cutaneous marginal zone lymphoma (<jats:styled-content style=\"fixed-case\">PCMZL<\/jats:styled-content>) is challenging, as clear\u2010cut immunophenotypical and cytogenetic criteria to segregate both entities are lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>To characterize <jats:styled-content style=\"fixed-case\">PCFL<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">PCMZL<\/jats:styled-content> more clearly and to define criteria helpful for the differential diagnosis, we compared expression of immunohistochemical markers [<jats:styled-content style=\"fixed-case\">LIM<\/jats:styled-content>\u2010only transcription factor 2 (<jats:styled-content style=\"fixed-case\">LMO<\/jats:styled-content>2), human germinal centre\u2010associated lymphoma (<jats:styled-content style=\"fixed-case\">HGAL<\/jats:styled-content>), stathmin 1 (<jats:styled-content style=\"fixed-case\">STMN<\/jats:styled-content>1), activation\u2010induced cytidine deaminase (<jats:styled-content style=\"fixed-case\">AID<\/jats:styled-content>), myeloid cell nuclear differentiation antigen (<jats:styled-content style=\"fixed-case\">MNDA<\/jats:styled-content>)] and the presence of cytogenetic abnormalities described previously in nodal follicular lymphoma [B cell lymphoma 2 (<jats:italic>BCL2<\/jats:italic>) and <jats:italic>BCL6<\/jats:italic> breaks, 1p36 chromosomal region deletion (del 1p36)] in a series of 48 cutaneous follicular and marginal zone lymphomas [cutaneous follicular lymphoma (<jats:styled-content style=\"fixed-case\">CFL<\/jats:styled-content>) and cutaneous marginal zone lymphoma (<jats:styled-content style=\"fixed-case\">CMZL<\/jats:styled-content>)]. Immunostaining for <jats:styled-content style=\"fixed-case\">STMN<\/jats:styled-content>1, <jats:styled-content style=\"fixed-case\">LMO<\/jats:styled-content>2, <jats:styled-content style=\"fixed-case\">HGAL<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">AID<\/jats:styled-content> allowed the distinction between <jats:styled-content style=\"fixed-case\">CFL<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">CMZL<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">STMN<\/jats:styled-content>1 was the most sensitive marker (100% <jats:styled-content style=\"fixed-case\">CFL<\/jats:styled-content>, 0% <jats:styled-content style=\"fixed-case\">CMZL<\/jats:styled-content>). <jats:styled-content style=\"fixed-case\">LMO<\/jats:styled-content>2, <jats:styled-content style=\"fixed-case\">HGAL<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">AID<\/jats:styled-content> were positive in 93.2%, 82.1% and 86.2% <jats:styled-content style=\"fixed-case\">CFL<\/jats:styled-content> (all <jats:styled-content style=\"fixed-case\">CMZL<\/jats:styled-content>\u2010negative). <jats:styled-content style=\"fixed-case\">MNDA<\/jats:styled-content> was expressed in both entities without significant difference (10.3% <jats:styled-content style=\"fixed-case\">CFL<\/jats:styled-content>, 30.8% <jats:styled-content style=\"fixed-case\">CMZL<\/jats:styled-content>,<jats:italic> P<\/jats:italic> = 0.18). <jats:italic><jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content>2<\/jats:italic>,<jats:italic> <jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content>6<\/jats:italic> breaks and the del 1p36 were present in 16.7%, 10.7% and 18.5% <jats:styled-content style=\"fixed-case\">CFL<\/jats:styled-content> and no <jats:styled-content style=\"fixed-case\">CMZL<\/jats:styled-content>. Finally, three and 29 <jats:styled-content style=\"fixed-case\">CFL<\/jats:styled-content> were reclassified as secondary cutaneous follicular lymphomas (<jats:styled-content style=\"fixed-case\">SCFL<\/jats:styled-content>) and <jats:styled-content style=\"fixed-case\">PCFL<\/jats:styled-content> without significant differences concerning phenotypical and cytogenetic features. <jats:italic><jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content>2<\/jats:italic>,<jats:italic> <jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content>6<\/jats:italic> breaks and the del 1p36 were present in 11.1%, 8% and 16.7% <jats:styled-content style=\"fixed-case\">PCFL<\/jats:styled-content> and did not impact the prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LMO2, <jats:styled-content style=\"fixed-case\">HGAL<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> STMN<\/jats:styled-content>1 and <jats:styled-content style=\"fixed-case\">AID<\/jats:styled-content>, but not <jats:styled-content style=\"fixed-case\">MNDA<\/jats:styled-content>, are discriminant for the recognition between <jats:styled-content style=\"fixed-case\">CFL<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">CMZL<\/jats:styled-content>. <jats:italic><jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content>2<\/jats:italic>,<jats:italic> <jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content>6<\/jats:italic> rearrangements and the del 1p36 have a role in the pathogenesis of <jats:styled-content style=\"fixed-case\">PCFL<\/jats:styled-content>, the latest being the most common alteration.<\/jats:p><\/jats:sec>","DOI":"10.1111\/his.13279","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T10:12:45Z","timestamp":1496916765000},"page":"648-660","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Diagnostic value of <scp>STMN<\/scp>1, <scp>LMO<\/scp>2, <scp>HGAL<\/scp>,<scp> AID<\/scp> expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas"],"prefix":"10.1111","volume":"71","author":[{"given":"Evelyne","family":"Verdanet","sequence":"first","affiliation":[{"name":"D\u00e9partement de Biopathologie CHU Montpellier H\u00f4pital Gui De Chauliac Montpellier France"},{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dereure","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"},{"name":"D\u00e9partement de Dermatologie CHU Montpellier H\u00f4pital Saint Eloi Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Ren\u00e9","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"},{"name":"D\u00e9partement d'Immunologie CHU Montpellier H\u00f4pital Saint Eloi Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Tempier","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Biopathologie CHU Montpellier H\u00f4pital Gui De Chauliac Montpellier France"},{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Benammar\u2010Hafidi","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Biopathologie CHU Montpellier H\u00f4pital Gui De Chauliac Montpellier France"},{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Gallo","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Biopathologie CHU Montpellier H\u00f4pital Gui De Chauliac Montpellier France"},{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Frouin","sequence":"additional","affiliation":[{"name":"Service Anatomie et Cytologie Pathologiques CHU Poitiers Poitiers France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Durand","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Biopathologie CHU Montpellier H\u00f4pital Gui De Chauliac Montpellier France"},{"name":"MEDIPATH Grabels France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gazagne","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"},{"name":"D\u00e9partement d'H\u00e9matologie biologique CHU Montpellier H\u00f4pital Saint Eloi Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Costes\u2010Martineau","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Biopathologie CHU Montpellier H\u00f4pital Gui De Chauliac Montpellier France"},{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e8re","family":"Cacheux","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"},{"name":"D\u00e9partement d'H\u00e9matologie biologique CHU Montpellier H\u00f4pital Saint Eloi Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2777-9910","authenticated-orcid":false,"given":"Vanessa","family":"Szablewski","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Biopathologie CHU Montpellier H\u00f4pital Gui De Chauliac Montpellier France"},{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 Montpellier 1 Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2005.00495.x"},{"key":"e_1_2_7_4_1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow S","year":"2017"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02951.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181e9343d"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.12076"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.04.004"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2014.11.006"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402707"},{"key":"e_1_2_7_11_1","first-page":"4649","article-title":"BCL6\u2010translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH\/BCL2","volume":"29","author":"Gollub W","year":"2009","journal-title":"Anticancer Res."},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168682"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000567"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.108"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-039024"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3112"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.120956"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP7Z2BIBUNQPLZ"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.51"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200206000-00006"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02501.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP4SUBR4NPSPTN"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-015-1864-y"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1689"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000126775.27698.6e"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.3.647"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000146015.22624.c7"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200604000-00015"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200107000-00005"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371768"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.862"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhis.13279","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.13279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T16:28:59Z","timestamp":1696350539000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/his.13279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1111\/his.13279"],"URL":"https:\/\/doi.org\/10.1111\/his.13279","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]},"assertion":[{"value":"2017-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}